EUVIMEDObjevte EUVIMED
Open access

Early success of the COCOON trial: Preventing dermatologic adverse events in first-line EGFR-mutant NSCLC

Bishal Tiwari, Asmita Koirala

Oncoscience · 2026-03-11 · 13 · 69-76

DOI: 10.18632/oncoscience.648 ↗

At a glance

Journal article in Oncoscience, published on 2026-03-11. Written by Bishal Tiwari and 1 co-authors. Institution: Nassau University Medical Center, East Meadow, NY 11554, USA. 11 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Subjects

Author keywords

COCOON trialEGFR-mutant non-small cell lung canceramivantamabdermatologic adverse eventslazertinib

Authors and institutions

  • Nassau University Medical Center, East Meadow, NY 11554, USA.
  • Western Regional Hospital, Pokhara, Nepal.

Cite

APA

Tiwari, B., & Koirala, A. (2026). Early success of the COCOON trial: Preventing dermatologic adverse events in first-line EGFR-mutant NSCLC. Oncoscience, 13, 69-76. https://doi.org/10.18632/oncoscience.648

Vancouver

Tiwari B, Koirala A. Early success of the COCOON trial: Preventing dermatologic adverse events in first-line EGFR-mutant NSCLC. Oncoscience. 2026;13:69-76. doi:10.18632/oncoscience.648

BibTeX
@article{Tiwari2026,
  author = {Tiwari, Bishal and Koirala, Asmita},
  title = {Early success of the COCOON trial: Preventing dermatologic adverse events in first-line EGFR-mutant NSCLC},
  journal = {Oncoscience},
  year = {2026},
  volume = {13},
  pages = {69--76},
  doi = {10.18632/oncoscience.648}
}
Start for free →